Anti‐tumor activity of mesenchymal stem cells producing IL‐12 in a mouse melanoma model
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent a new tool for delivery of therapeutic agents to tumor cells. In this study, we have evaluated the anti‐tumor activity of human MSCs stably transduced with a retroviral vector expressing the cytokine interleukin‐12 (IL‐12) in a mouse melanoma model. Application of MSC(IL‐12) but not control MSCs strongly reduced the formation of lung metastases of B16F10 melanoma cells. The activity of the MSC(IL‐12) cells was dependent on the presence of natural killer (NK) cells in this experimental setting. Further, MSC(IL‐12) cells elicited a pronounced retardation of tumor growth and led to prolonged survival when injected into established subcutaneous melanoma in a therapeutic regimen. The therapeutic effect of the MSC(IL‐12) was in part mediated by CD8+ T cells, while NK cells and CD4+ T cells appeared to play a minor role. The anti‐tumor effect of MSC(IL‐12) cells was of similar efficiency as observed for application of naked plasmid DNA encoding IL‐12. The presented data demonstrate that these two different strategies can induce a similar therapeutic anti‐tumor efficacy in the mouse melanoma tumor model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y., & Hamada, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302276 · Cited by 597 · cited 3×
“Following ConA/ IL-2-induced blastogenesis, splenocytes were allowed to rest in serum-free media for 1 day (30).”
Background
Cited by
Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
Shi, Y., Du, L., Lin, L., & Wang, Y. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.193 · Cited by 460
Localized Interleukin-12 for Cancer Immunotherapy
Nguyen, K. G., Vrabel, M. R., Mantooth, S. M., Hopkins, J. J., Wagner, E. S., Gabaldon, T. A., & Zaharoff, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575597 · Cited by 431
Targeting the tumor stroma for cancer therapy
Xu, M., Zhang, T., Xia, R., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01670-1 · Cited by 319
Recent advances into the understanding of mesenchymal stem cell trafficking
Fox, J. M., Chamberlain, G., Ashton, B. A., & Middleton, J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06610.x · Cited by 303
Pierigè, F., Serafini, S., Rossi, L., & Magnani, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.029 · Cited by 295
Metadata
- Authors
- Elzaouk, L., Moelling, K., & Pavlovic, J.
- Venue
- Experimental Dermatology
- Publisher
- Wiley
- Published
- 2006-09-26
- Volume
- 15
- Issue
- 11
- Pages
- 865-874
- ISSN
- 0906-6705 (ISSN-L)
- 1600-0625
- OpenAlex
- W2020794309
- Cited by
- 128
- References
- 2
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti‐tumor activity of mesenchymal stem cells producing IL‐12 in a mouse melanoma model. https://app.cochat.ai/papers/10.1111/j.1600-0625.2006.00479.x
- The paper
- Elzaouk, L., Moelling, K., & Pavlovic, J. (2006). Anti‐tumor activity of mesenchymal stem cells producing IL‐12 in a mouse melanoma model. Experimental Dermatology. https://doi.org/10.1111/j.1600-0625.2006.00479.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.